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Abstract
Background: Protein phosphatase one (PP1) is a ubiquitously expressed, highly conserved protein
phosphatase that dephosphorylates target protein serine and threonine residues. PP1 is localized
to its site of action by interacting with targeting or regulatory proteins, a majority of which contains
a primary docking site referred to as the RVXF/W motif.
Results: We demonstrate that a peptide based on the RVXF/W motif can effectively displace PP1
bound proteins from PP1 retained on the phosphatase affinity matrix microcystin-Sepharose.
Subsequent co-immunoprecipitation experiments confirmed that each identified binding protein
was either a direct PP1 interactor or was in a complex that contains PP1. Our results have linked
PP1 to numerous new nuclear functions and proteins, including Ki-67, Rif-1, topoisomerase IIα,
several nuclear helicases, NUP153 and the TRRAP complex.
Conclusion: This modification of the microcystin-Sepharose technique offers an effective means
of purifying novel PP1 regulatory subunits and associated proteins and provides a simple method
to uncover a link between PP1 and additional cellular processes.
Background
The phosphorylation of proteins is one of the most prev-
alent covalent modifications known, affecting essentially
every aspect of cellular function [1,2]. The protein kinases
and phosphatases responsible are highly conserved across
species and, with few exceptions, the kinases belong to
one large gene family while the phosphatase complement
is more complex and can be divided into three broad
groups based on protein sequence, catalytic signature and
substrate preference [3-5]. The action of protein phos-
phatases is tightly controlled with cellular targeting being
an important means of regulation. Most phospho-serine
and threonine dephosphorylation can be attributed to the
PPM family and the more diverse PPP family, which
includes PP1, PP2A, PP2B, and PP4 through to PP7. PP1
is thought to not exist as a free catalytic subunit in the cell,
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but to reside in complexes with a large array of targeting
or regulatory subunits that define its function. Numerous
PP1 docking proteins have been identified, but they most
likely represent only a small fraction of the total number
in the cell.
The microcystins are a group of cyclic peptides that bind
with remarkable specificity and affinity to the type one, 2A
and several recently identified protein phosphatases of the
PPP family (e.g. PP4, PP6). Microcystin covalently cou-
ples to a conserved cysteine residue of PPP family mem-
bers through its methyl-dehydroalanine residue [6,7].
Nishiwaki et al [8] first used Microcystin-Sepharose to
purify PP2A. We exploited a different synthetic approach
whereby the carbon-carbon double bond of methyl-dehy-
droalanine in microcystin couples the latter to ami-
noethanethiol, which is then linked to a Sepharose bead.
This generates a high affinity binding matrix for the
microcystin-sensitive protein phosphatases that does not
covalently couple the phosphatase [6]. Microcystin-
Sepharose has proved to be a powerful tool to purify these
protein phosphatases and their associated regulatory sub-
units from a variety of tissues and cell types [9-12].
With only a few characterized exceptions, PP1 interacting
proteins bind PP1 through their primary docking
sequence called the RVXF/W motif [13]. Their molecular
interaction with PP1 has been visualized via PP1-peptide
and PP1 regulatory subunit structures [14,15]. It has also
emerged that additional or secondary interaction sites
often play a role in binding PP1 and likely contribute to
PP1 isoform specificity recognition, substrate docking and
modulation of PP1 activity [13,15-20]. Based on a compi-
lation of demonstrated RVXF/W interaction motifs [21-
23], the panning of a random peptide library [24], and
mutagenesis and modeling studies [23] we noted prefer-
ences for particular amino acids within and adjacent to
the RVXF/W motif. This led us to speculate that a PP1
interaction motif peptide, based on this comparison,
could be a unique means to specifically disrupt PP1-tar-
getting or regulatory subunit interactions [14,25,26].
Slight variation in the RVXF/W-motif combined with the
now recognized additional, secondary PP1 interaction
sites provide sufficient interaction specificity which may
allow the development of drugs or peptide mimetics to
abolish specific PP1 binding protein interactions in vivo.
The idea of targeting protein-protein interaction domains
with drugs has historically not been favored by the phar-
maceutical industry yet, due to improved understanding
of the underlying molecular mechanisms, it is now a con-
cept that is growing in popularity [27,28]. This idea has
been explored with PKA anchoring proteins (AKAPs)
where optimal RI and RII subunit binding peptides were
derived from parent peptides and used to target PKA in
vivo and displace it from its normal anchoring site [29]. In
addition to in vivo targeting, disrupting PP1-regulatory
subunit interactions with a peptide would be an effective
means to aid in identifying proteins in PP1 complexes and
thus uncover new cellular processes regulated by this pro-
tein phosphatase.
Results and Discussion
We initiated our PP1 peptide displacement study selecting
RVXF/W containing peptides from the PP1 targeting sub-
units NIPP1 [25,30] and ZAP (ZAP3) [31,32]. They were
synthesized and tested for their ability to displace PP1
binding proteins from complexes retained on the micro-
cystin matrix. In brief, we isolated rat liver nuclei,
extracted proteins and incubated extracts with Microcys-
tin-Sepharose to bind the microcystin-sensitive protein
phosphatases [31]. After extensive column washing, we
incubated the matrix with the NIPP1 or ZAP peptides
(RPKRKRKNSRVTFSEDDEII and GKKRVRWADLE,
respectively) to selectively displace proteins retained on
the matrix through PP1. This implies that PP1 itself and
other microcystin-sensitive phosphatase complexes
should be retained on the matrix and can subsequently be
eluted with the chaotrophic agent sodium thiocyanate
(NaSCN), which will also displace other bound proteins
[9] including some that may be retained by binding non-
specifically to the Sepharose bead. Blotting for PP1 and
the PP2A regulatory subunit PR65 show this to be true
(Figure 1a and 1b) with no retention of these phosphatase
subunits on a control matrix coupled with Tris alone. The
NIPP1 peptide (RPKRKRKNSRVTFSEDDEII) readily dis-
placed PP1 regulatory subunits (data not shown), yet we
chose to continue working with the ZAP peptide
(GKKRVRWADLE, later also referred to as RVRW peptide)
because it is small, readily soluble and an excellent match
to the optimal PP1 binding peptide discovered through
panning a random peptide library [24]. Indeed, the ZAP
peptide RVRW motif and the additional C-terminal
amino acids ADL and N-terminal basic amino acids (KK)
were most frequently obtained in the random peptide
library screen (Figure 2 in [24]). We thus predict that the
ZAP sequence GKKRVRWADLE is the most suitable, high
affinity peptide that will compete and displace most other
proteins docked to PP1 through variations of the RVXF/
W-motif. We acknowledge that even with an 'optimal
binding peptide' there are certainly other PP1 interacting
proteins on the matrix that may not be displaced because
of completely novel PP1 interaction sites and/or addi-
tional interaction sites outside of the RVXF/W-motif [20]
that could maintain the interaction with PP1 even if the
RVXF/W site is displaced. Thus, the PP1 binding partners
uncovered here still most likely only represent a sub-pop-
ulation of the total nuclear PP1 binding partners.
RVRW peptide eluted samples were blotted for the known
nuclear PP1 binding proteins ZAP, p99 (PNUTS) andBMC Biochemistry 2008, 9:28 http://www.biomedcentral.com/1471-2091/9/28
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Figure 1
A peptide based on the PP1 interaction motif RVXF/W displaces PP1 regulatory subunits from the affinity 
matrix microcystin-Sepharose. Proteins extracted from isolated rat liver nuclei were incubated with the affinity (MC) or 
control (Con) matrix (Tris coupled). Proteins were displaced with the RPKRKRKNSRVTFSEDDEII peptide (a), while in (b), 
elution was performed with either RPKRKRKNSRVTFSEDDEII or GKKRVRWADLE prior to the 3 M NaSCN elution. The 
control matrix is only used in the panel (a) experiment while microcystin-Sepharose is used in all others. After concentration, 
samples were run on 10% SDS-PAGE, blotted to nitrocellulose and membranes were probed with anti-PR65 and PP1 antibod-
ies. In panel (c) the membrane was probed with anti-ZAP, p99 or NIPP1 antibodies [31]. To test for the salt dependence of 
peptide displacement, columns were eluted with peptide plus or minus NaCl as indicated and samples blotted for NIPP1 (d). 
To determine optimal peptide concentration for displacement from the column, the protein loaded beads were divided into 3 
equal parts and eluted with 0.1, 0.5 and 2 mM peptide (e). To test for the specificity of the peptide displacement, the beads 
were divided into 3 equal parts and eluted with either GKKRVRWADLE, the GKKRVRWADLE peptide with the key inter-
acting residues changed to A (GKKRARAADLE), or a scrambled version of the GKKRVRWADLE peptide (KLRGEVAK-
DWR) and blotted for ZAP, p99 and NIPP1. Glycogen particles were isolated from rabbit skeletal muscle and PP1GM bound to 
the microcystin matrix followed by peptide elution first with the GKKRARAADLE peptide, then GKKRVRWADLE, followed 
by 3 M NaSCN.BMC Biochemistry 2008, 9:28 http://www.biomedcentral.com/1471-2091/9/28
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NIPP1 (Figure 1c). This revealed that these proteins were
readily displaced from the matrix by the peptide with
essentially no further regulatory subunit being eluted with
NaSCN. A direct comparison of elution conditions with
the GKKRVRWADLE peptide showed that displacement
was much more effective in a higher ionic strength buffer
(Figure 1d). Having established that the GKKRVRWADLE
peptide is an excellent tool to displace PP1 regulatory sub-
units, we tried several peptide concentrations to optimize
displacement from the matrix (Figure 1e). This demon-
strated that 0.1 mM peptide was sufficient to displace ZAP
and p99, but 0.5 to 2 mM peptide was needed to remove
all of the more abundant and perhaps higher affinity
binding NIPP1 protein. At the 2 mM peptide concentra-
tion we noted that displacement was in fact not as effec-
tive for ZAP or p99. In subsequent experiments we eluted
by first incubating with 0.5 mM, then 2 mM peptide to
ensure all PP1 complex proteins were displaced. To ensure
the specificity of the method, we included 2 independent
negative controls. Nuclear phosphatases bound to the
microcystin matrix were equally divided into 3 parts and
eluted with either the GKKRVRWADLE peptide, the
GKKRVRWADLE peptide where the key PP1 interacting
amino acids (V and W) were replaced by alanine (GKKRA-
RAADLE), or a scrambled ZAP peptide (KLRGEVAK-
DWR). These fractions were blotted for ZAP, p99 and
NIPP1 (Figure 1f) confirming the specificity of the dis-
placement technique.
To extend this method to PP1 complexes outside the
nucleus, we isolated glycogen particles from skeletal mus-
cle where the well characterized PP1 regulatory subunit
GM resides and functions to target PP1 to glycogen [22]. As
shown in Figure 1g, the peptide GKKRVRWADLE effec-
tively displaced GM from the microcystin-matrix. In addi-
tion, prior to the RVRW displacement, we performed an
incubation with the GKKRARAADLE peptide and, as pre-
dicted, due to the absence of the key V and W residues in
the docking motif, this peptide did not displace the GM
protein from the matrix which supports the idea that the
peptide elution is specific for PP1 complexes. All subse-
quent experiments included the GKKRARAADLE peptide
elution and buffer wash step prior to GKKRVRWADLE
peptide displacement.
Having developed this methodology, we scaled it up to
specifically release PP1 interacting proteins from the
matrix with the aim of identifying novel, less abundant
nuclear PP1 regulatory subunits and/or proteins that
reside in PP1 complexes. We predict many more unrecog-
nized PP1 regulatory subunits exist whose identification
may have been masked in previous studies when all
microcystin-sensitive phosphatases (especially the abun-
dant PP2A complex) and non-specifically bound proteins
were released from the matrix using NaSCN alone [31].
Furthermore, peptides may not be detected during mass
spectrometry in the presence of more abundant peptides.
Using an extract prepared from isolated rat liver nuclei we
could show that GKKRVRWADLE peptide displacement
gave a banding pattern on SDS-PAGE that was clearly dis-
tinct from the subsequent NaSCN elution [Additional file
1]. Individual GKKRVRWADLE eluted bands were excised
from the gel and proteins identified by mass spectrometry
[Additional file 2]. Many previously characterized and
new potential PP1 binding proteins were identified. To
validate our findings in different organisms, we then
switched our attention to the human HeLa cell line. Here
the GKKRARAADLE, GKKRVRWADLE and NaSCN col-
umn elutions again show distinct protein patterns (Fig
2a). Mass spectrometry identification of individual bands
from the GKKRVRWADLE displacement is shown in
Additional file 3 and file 4. For many of the identified pro-
teins we were able to obtain antibodies and blotting of the
individual elution steps confirmed that the GKKRARAA-
DLE peptide did not elute any of the known or putative
new PP1 interactors, supporting the idea that all of the
GKKRVRWADLE released proteins reside in PP1 com-
plexes and that many are direct PP1 binding proteins (Fig-
ure 2b). Of note is the abundant presence of putative PP1
docking sites within the sequences of identified proteins
(additional files 2 and 4). Although we predict only PP1
binding/complex proteins should elute with docking site
peptide, mass spectrometry reveals that some PP1 cata-
lytic and PP2A components did release with GKKRVRWA-
DLE elution, while blotting showed that the vast majority
of the total pool of these subunits were retained on the
matrix (Figure 2b). This is not surprising given that some
complexes likely contain both PP1 and PP2A [33] and
other proteins may contain more than one PP1 dock site.
The lack of displacement with the GKKRARAADLE pep-
tide, and subsequent elution with GKKRVRWADLE pro-
vide compelling evidence that PP1 directly docks or is in
these protein complexes. To explore this further we per-
formed immunoprecipitations with antibodies we
obtained for many of these proteins and in every instance
tested we could demonstrate the interaction with PP1
(Figure 3). These data again support the idea that we spe-
cifically eluted PP1 complex proteins from the matrix.
One reason for using the RVRW peptide elution was to
specifically displace proteins and not release any polypep-
tides that associate non-specifically. It is known that some
proteins bind non-specifically to Sepharose beads and
thus we sought to determine if the proteins discovered
here were retained on Sepharose alone and eluted with
the GKKRVRWADLE peptide. Therefore, as an additional
control, we passed a HeLa nuclear extract over Sepharose
beads alone, washed as usual, then eluted with the
GKKRARAADLE and GKKRVRWADLE peptides and
NaSCN, as described for the microcystin-matrix. These
samples were then western blotted for a selection of inter-BMC Biochemistry 2008, 9:28 http://www.biomedcentral.com/1471-2091/9/28
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Displacement affinity chromatography purification of PP1 complexes from HeLa cell nuclei Figure 2
Displacement affinity chromatography purification of PP1 complexes from HeLa cell nuclei. (a) A HeLa cell 
nuclear extract was incubated with microcystin-Sepharose, washed extensively and eluted with the GKKRARAADLE peptide, 
followed by GKKRVRWADLE peptide and finally with 3 M NaSCN. Each fraction was concentrated to an equal volume, run 
on 4–12% SDS-PAGE (Invitrogen) and stained with Collodial blue. Individual bands were excised, trypsin digested and identified 
by mass spectrometry (see Additional files 2 and 4). In (b) the same samples from panel (a) were blotted to a membrane and 
probed with antibodies to proteins identified by mass spectrometry. Protein names are defined in abbreviations list.BMC Biochemistry 2008, 9:28 http://www.biomedcentral.com/1471-2091/9/28
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actors that were previously retained on the microcystin-
Sepharose and eluted with the GKKRVRWADLE peptide
(Figure 2b). When the entire GKKRARAADLE, GKKRVR-
WADLE and NaSCN fractions were individually concen-
trated and run on a single lane and blotted versus 1/175
of the input (which gave a strong western signal) we did
weakly detect several of these proteins in the NaSCN elu-
tion (as expected), but only noted signals for filamin A
and PSF in the GKKRVRWADLE peptide elution (data not
shown). Given that this is in comparison to 1/175 of the
input, this represents a very minor background displace-
ment and functions to remind us that, as in any explora-
tory work, additional experiments are needed to confirm
true interactors. Interestingly, PSF has previously been
defined as a PP1 docking protein [34].
It is notable from the mass spectrometry data that we
identified many nuclear processes or complexes not previ-
ously linked to PP1. For instance, we found numerous
TIP60 (TRRAP) complex proteins [35]. Immunoprecipita-
tion of the TIP60 components TRRAP or p400 (Domino)
were able to bring down PP1, confirming that PP1 is a pre-
viously unrecognized component of this complex. Puta-
tive interacting proteins or complexes identified here will
need to be confirmed by co-immunoprecipitation experi-
ments or other methods, and then ultimately all com-
plexes, including the TRRAP complex, will need to be
studied to define the role of PP1 binding to that protein
or group of proteins.
A comparison of the proteins eluted and identified from
rat and human nuclei reveals that most of the proteins are
the same (although the number of rat proteins is greater),
but several differences are apparent. First, some differ-
ences are not surprising given that the HeLa cell line
expresses numerous proteins that differ from the rat liver
cell proteome. In addition, there are quite a number of
proteins in the rat samples that appear in multiple bands
excised from the gel, but this only occurs a few times in
the HeLa bands. This is likely due to the fact that prepara-
tion of the rat nuclei from liver tissue is more time con-
Figure 3
Co-immunprecipitation of PP1 with HeLa nuclear PP1 bind- ing and complex proteins Figure 3
Co-immunprecipitation of PP1 with HeLa nuclear 
PP1 binding and complex proteins. Antibodies were 
obtained for the proteins shown and immunoprecipitations 
performed. Immunoprecipitated proteins were run on SDS-
PAGE, transferred to a membrane and probed with the same 
antibodies as indicated plus a pan PP1 antibody to determine 
if PP1 co-immunoprecipitates. The immunoprecipitating anti-
body is shown on the left and in all cases a pre-immune 
serum control was done in parallel (PIS). The blotting anti-
body it indicated on the right.BMC Biochemistry 2008, 9:28 http://www.biomedcentral.com/1471-2091/9/28
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suming and thus we expect increased proteolysis of
proteins and therefore many more hits of the same pro-
tein in bands of many masses. Comparing rat liver versus
cells grown in culture also means that we started with
much more protein from the rat preparation and this cer-
tainly contributed to the identification of more lower
abundance proteins.
To date several approaches have been used to define the
PP1-interactome of the cell, including total (NaSCN) elu-
tion from microcystin-Sepharose followed by overlay
analysis, SILAC mass spectrometry based PP1 binding
partner investigation and most recently an antibody array
approach for selected putative targets [11,31,36,37]. Any
methodology has its limitations; our work certainly repre-
sents a subgroup of the total PP1 targeted protein/com-
plexes of the nucleus for reasons discussed above and
because our nuclear extraction procedure likely only
released some fraction of the total PP1 complexes. It is
clear that many more PP1 binding partners exist than orig-
inally thought and it will be the combination of multiple
approaches that will ultimately define the plethora of
roles for PP1 in the nucleus and other cellular compart-
ments.
Conclusion
We have developed a method to specifically elute proteins
that reside in PP1 complexes or bind directly to PP1 after
retention on the affinity matrix microcystin-Sepharose.
This approach should be valuable to isolate new PP1
binding proteins and to link PP1 function to as yet unrec-
ognized PP1 regulated cellular processes across a broad
range of tissues, cell types and organisms. This technique
also lends further credibility to the notion that it could be
possible to develop peptides as tools for the specific dis-
ruption of protein protein interactions with potential
usage for therapeutic purposes.
Methods
HeLa nuclear extracts
For HeLa cells, nuclei were isolated and extracted from ~1
× 109 cells grown in spinner flasks using the method out-
lined at http://www.lamondlab.com. Sonicated, extracted
nuclei were made to 0.42 M NaCl, mixed end-over-end for
10 min. at 4°C and clarified by centrifugation at 10,000 g
for 10 min. This clarified extract was then mixed with the
microcystin matrix.
Affinity displacement chromatography
Microcystin-Sepharose was prepared as described [7,9].
Control matrix was prepared by coupling to Tris instead of
aminoethanethiol-microcystin. In a typical nuclear prepa-
ration, the livers of 10 rats were homogenized, nuclei iso-
lated and proteins extracted [31]. Nuclear proteins were
incubated end over end with 1 mL of microcystin-Sepha-
rose or control matrix for 1 h at 4°C and then washed in
a column with 250 mL of buffer A (25 mM Tris-HCl pH
7.5, 0.1 mM EGTA, 1 mM benzamidine, 0.1 mM PMSF,
0.1% β-ME) plus 300 mM NaCl. All peptides were dis-
solved in buffer A plus 300 mM NaCl and the pH adjusted
to 7.5 with 1 N NaOH by spotting on pH paper. The
matrix (1 mL) was first incubated with 2 mL 0.5 mM pep-
tide for 30 min. and the eluted protein collected with the
addition of 2 mL buffer A plus 300 mM NaCl. The matrix
was then incubated with 2 mL 2 mM peptide for 30 min.
and the eluted protein collected with the addition of 5 mL
buffer A plus 300 mM NaCl. After washing with an addi-
tional 30 mL of buffer A plus 300 mM NaCl, the column
was eluted with 3 M sodium isothiocyanate in buffer A
[9]. The peptides used were RPKRKRKNSRVTFSEDDEII
(from human NIPP1), GKKRVRWADLE (from human
ZAP), GKKRARAADLE (from human ZAP with alanine
substitutions for V and W) and KLRGEVAKDWR (scram-
bled GKKRVRWADLE). The 0.5 and 2 mM peptide elu-
tions were pooled and immediately concentrated in a
centriprep 10, then centricon 10 to 40 μL and boiled in 5×
SDS-cocktail. The NaSCN elution was dialyzed extensively
and concentrated to 40 μL as described for the peptide
elutions and boiled in 5× SDS-cocktail. Samples were run
on 10% SDS-PAGE or in some cases on 4–12% gradient
gels (Invitrogen).
Isolation of rabbit skeletal muscle glycogen particles and 
chromatography on MC-Sepharose
Skeletal muscle from the back and hind legs of one rabbit
was removed, placed on ice, minced and homogenized
with 2.5 L/kg homogenization buffer (2 mM EDTA, 2 mM
EGTA, 0.1% B-ME, 1 mM benzamidine, 0.1 mM PMSF) in
a blender and centrifuged in a Beckman J6 at 4200 rpm for
30 min. at 4°C. The supernatant was decanted through
glass wool in a funnel and the pH of the solution lowered
to 6.1 with 1 M acetic acid. After 15 min on ice, glycogen
was pelleted by centrifugation at 4200 rpm for 30 min. at
4°C. The glycogen pellet was resuspend in 100 mL of the
following buffer (50 mM Tris-HCl pH 7, 2 mM EGTA, 5%
V/V glycerol, 4 μg/mL leupeptin, 1 mM benzamidine, 0.1
mM PMSF, and 0.1% β-ME.) and loaded on a 1 mL micro-
cystin-Sepharose column equilibrated with microcystin-
Sepharose buffer A. After incubation for 1.5 hour with an
end-over-end machine, then washing with microcystin-
Sepharose buffer A plus 0.3 M NaCl (200 column vol-
umes or until no protein comes off in a Bradford assay)
the matrix was eluted with peptides and NaSCN as
described above.
Mass spectrometry
For protein identification by mass spectrometry bands
were excised from colloidal blue stained gels, digested
with trypsin and LC-MS/MS was performed as in Ulke-
Lemée et al [32]. Peak lists were searched with MudpitBMC Biochemistry 2008, 9:28 http://www.biomedcentral.com/1471-2091/9/28
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scoring using Mascot version (v2.2). We used the criteria
of 2 matching peptides for a positive identification.
Immunoprecipitations
Antibodies to proteins or an equivalent amount of pre-
immune serum purified IgG were coupled to Protein A-
Sepharose (GE Healthcare) and incubated with HeLa cell
extracts (from 4 × 10 cm plates) end over end for 2 h at
4°C. After sedimentation, IP pellets were washed 2× with
PBS, 2× with PBS plus 0.05% NP-40 and 150 mM NaCl
and 2 more times in PBS, before boiling in SDS-cocktail.
In all cases, antibody and pre-immune serum IPs were
incubated with identical amounts of protein, washed in
parallel and eluted with an equal volume of cocktail to
allow direct comparison on western blots.
Antibodies were kindly provided by individuals or pur-
chased as indicated in brackets. PP1, NIPP1, p99
(PNUTS), SAP155, ZAP and their use are detailed in Tran
et al [31]. Other antibodies were PR65 (B. Hemmings),
GM  and M110 (P. Cohen), DPK-1 (SP Lees-Miller),
NUP153 (M. Lohka), DDX5 (F. Fuller-Pace), RAVER-1 (B.
Jockusch), TOPOIIα (E. Kurz), TRRAP, Envoplakin,
HDAC6, PSF (Santa Cruz), Ki-67, p53bp2 [ASPP2],
p54nrb/nono (BD Biosciences), Rif-1, p84 [Thoc1], P400
(Abcam), Filamin-A (Chemicon), NUMA-1 (Nova Biolog-
icals), DDX18, DDX17 [DNA helicaseA] (Bethyl Lab),
HDAC1 (Cell Signaling), PP2A-C (Transduction Labs).
Abbreviations
DPK1: DNA-dependent protein kinase; TRRAP: transfor-
mation/transcription domain-associated protein; RIF1:
Rap1-interacting factor 1; NUMA-1: nuclear mitotic appa-
ratus protein 1; TOPOIIα: topoisomerase IIα; SAP155:
spliceosome-associated protein 155; NUP153: nucleop-
orin 153; M110/MYPT1: myosin targeting subunit 110;
p53bp2: p53 binding protein 2; PSF: PTB-associated splic-
ing factor; RAVER1: ribonucleoprotein: PTB-binding 1;
PR65: PP2A scaffolding or A subunit; p400/Domino:
E1A-binding protein p400; ASPP: apoptosis stimulating
proteins of p53; NaSCN: sodium isothiocyanate; HDAC:
histone deacetylase; DDX: DEAD box family of RNA heli-
cases; PP1: protein phosphatase one; PP2A: protein phos-
phatase 2A; LCP1: epidermal Langerhans cell protein;
KPI-2: Kinase/Phosphatase/Inhibitor-2; NIPP: nuclear
inhibitor of protein phosphatase-1: ZAP (ZAP3): YLPM-
motif contain PP1 interactor; p99: PP1 interactor (also
PNUTS); GM: skeletal muscle glycogen binding PP1 inter-
actor; MC: microcystin; p84/Thoc1: THO complex 1;
p54nrb/nono: 54 kDa nuclear RNA binding protein;
NUP50: nucleoporin 50; TIP49a/RUVBL2: TBP-interact-
ing protein 49/RuvB-like 2; PP4: protein phosphatase
four; Repo-Man: recruits PP1 onto mitotic chromatin at
anaphase; MBS85: myosin-binding subunit of 85 kDa;
LRR-Ri: Leucine-rich repeats (LRRs): ribonuclease inhibi-
tor; GRP78: Glucose-Regulated Protein of 78-kDa.
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Additional material
Additional file 1
Supplementary Figure 1. Identification of novel rat liver nuclear PP1 
binding and complex proteins by displacement affinity chromatogra-
phy. Protein was extracted from isolated rat liver nuclei, incubated with 
microcystin-Sepharose, the matrix washed extensively and eluted with 
GKKRVRWADLE peptide, followed by elution with 3 M NaSCN [31]. 
GKKRVRWADLE and NaSCN eluted samples were concentrated sepa-
rately to an equal volume and run on 10% SDS-PAGE and stained with 
Collodial blue. In a parallel experiment, the bands shown above were 
excised, trypsin digested and analyzed by mass spectrometry for identifica-
tion. The top matched identified proteins for each band(s) are indicated 
to the left of the figure. Additional matches for each excised band and 
details of protein identifications are in Additional file 2 online.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2091-9-28-S1.jpeg]
Additional file 2
Additional file 2-Supplementary Table 1. Identification of proteins 
eluted from microcystin-Sepharose using an 'RVRW' peptide (Rattus 
norvegicus). Proteins were run on SDS-PAGE and stained with Collodial 
blue. Individual bands were excised, digested with trypsin and proteins 
identified by Mass Spectrometry. These proteins are shown by gel band 
excised with and protein name/description, gene accession numbers, gene 
name and whether they were previously identified has a PP1 targeting 
subunit (Known PP1 TS).
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2091-9-28-S2.xls]
Additional file 3
Supplementary Figure 2. Identification of HeLa nuclear PP1 binding 
and complex proteins by displacement affinity chromatography. The 
GKKRVRWADLE elution from Figure 2a has been cropped and the top 
match identified proteins for each band(s) are indicated on the figure. 
Additional matches for each excised band and details of protein identifi-
cations are in Additional file 4 (Supplementary Table 2) online.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2091-9-28-S3.jpeg]BMC Biochemistry 2008, 9:28 http://www.biomedcentral.com/1471-2091/9/28
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